Table 38:
Net Budget Impact of Cost Reductions for Continuous Glucose Monitoring Devices
| Intervention | Year 1, $ | Year 2, $ | Year 3, $ | Year 4, $ | Year 5, $ |
|---|---|---|---|---|---|
| Funding CGM Based on a Conservative Projection of a 20% Annual Increase | |||||
| Device cost | 13,663,640 | 16,396,368 | 19,675,642 | 23,610,770 | 28,332,924 |
| Device cost + 75% sensor cost | 11,396,928 | 13,676,314 | 16,411,577 | 19,693,892 | 23,632,670 |
| Device cost reduced by 30% | 6,394,826 | 7,673,791 | 9,208,550 | 11,050,260 | 13,260,312 |
| Funding CGM for Entire Population With Hypoglycemia Unawareness | |||||
| Device cost | 121,695,684 | 125,704,689 | 129,684,091 | 133,627,989 | 137,530,346 |
| Device cost + 75% sensor cost | 99,975,005 | 103,254,454 | 106,505,923 | 109,724,341 | 112,904,518 |
| Device cost reduced by 30% | 55,746,044 | 57,539,926 | 59,309,134 | 61,050,287 | 62,759,917 |
| Funding CGM for Entire Type 1 Diabetes Population | |||||
| Device cost | 486,782,736 | 502,818,757 | 518,736,363 | 534,511,956 | 549,760,390 |
| Device cost + 75% sensor cost | 399,900,019 | 413,017,815 | 426,023,690 | 438,897,364 | 451,257,077 |
| Device cost reduced by 30% | 222,984,175 | 230,159,706 | 237,236,538 | 244,201,146 | 250,678,673 |
Abbreviations: CGM, continuous glucose monitoring.